Q-Med

From WikiCover

Q-Med AB is a rapidly growing and profitable biotechnology/medical device company. The company develops, manufactures, markets and sells primarily medical implants for esthetic and medical use. The majority of the products are based on the company's patented technology, NASHA for the production of stabilized non-animal hyaluronic acid. Sales are made through the company's own subsidiaries or distributors in over seventy countries. Q-Med today has just over six hundred co-workers, with approximately four hundred at the company's head office and production facility in Uppsala, Sweden. Q-Med AB is listed in the Large Cap segment of the OMX Nordic Exchange in Stockholm.

Headquarters: Uppsala, Sweden